Literature DB >> 22690275

Primary dedifferentiated liposarcoma of the axilla arising in a mixed, well-differentiated and myxoid liposarcoma.

Garth S Campbell1, Thomas J Lawrence, Scott E Porter, Luminita Rezeanu.   

Abstract

We describe a case of mixed liposarcoma of the axilla presenting as a high grade undifferentiated sarcoma with areas of well-differentiated and myxoid liposarcoma. MRI demonstrated a lobulated, septated intermuscular mass with marked heterogeneous gadolinium enhancement. A small focus of the tumor demonstrated fat suppressed signal more characteristic of well-differentiated liposarcoma. Pathologic analysis following wide local excision revealed a large, high grade sarcomatous component with highly pleomorphic cells with a thin rim of well-differentiated and myxoid liposarcoma on histologic examination. Dedifferentiated liposarcomas arising outside of the retroperitoneum are very rare, as are dedifferentiated liposarcomas arising from a histologically mixed liposarcoma. In this regard, this case illustrates an unusual combination of tumor location and histology which, to our knowledge, has not previously been reported.

Entities:  

Keywords:  Liposarcoma; axilla; magnetic resonance imaging; myxoid; upper extremity

Mesh:

Year:  2012        PMID: 22690275      PMCID: PMC3370706          DOI: 10.3941/jrcr.v6i1.867

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  14 in total

1.  Liposarcoma-the Malignant Tumor of Lipoblasts.

Authors:  A P Stout
Journal:  Ann Surg       Date:  1944-01       Impact factor: 12.969

2.  Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma.

Authors:  T Mentzel; C D Fletcher
Journal:  Histopathology       Date:  1997-05       Impact factor: 5.087

Review 3.  Imaging of primary chest wall tumors with radiologic-pathologic correlation.

Authors:  Se Jin Nam; Sungjun Kim; Beom Jin Lim; Choon-Sik Yoon; Tae Hoon Kim; Jin-Suck Suh; Doo Hoe Ha; Jong Won Kwon; Young Cheol Yoon; Hye Won Chung; Mi Sook Sung; Yun Sun Choi; Jang Gyu Cha
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

4.  Liposarcoma of soft tissue: MRI findings with pathologic correlation.

Authors:  R Arkun; A Memis; T Akalin; E E Ustun; D Sabah; G Kandiloglu
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

5.  Liposarcoma: a study of 55 cases with a reassessment of its classification.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1979-12       Impact factor: 6.394

6.  Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.

Authors:  J M Meis-Kindblom; H Sjögren; L G Kindblom; A Peydró-Mellquist; E Röijer; P Aman; G Stenman
Journal:  Virchows Arch       Date:  2001-08       Impact factor: 4.064

7.  Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor.

Authors:  John H Edmonson; Ivy A Petersen; Thomas C Shives; Michelle R Mahoney; Michael G Rock; Michael G Haddock; Franklin H Sim; William J Maples; Mary I O'Connor; Leonard L Gunderson; May L Foo; Douglas J Pritchard; Jan C Buckner; Scott L Stafford
Journal:  Cancer       Date:  2002-02-01       Impact factor: 6.860

8.  Radionuclide imaging of lipoma and liposarcoma.

Authors:  F S Chew; T M Hudson
Journal:  Radiology       Date:  1980-09       Impact factor: 11.105

9.  Dedifferentiated liposarcoma of the extremities: imaging findings in four patients.

Authors:  M J Kransdorf; J M Meis; J S Jelinek
Journal:  AJR Am J Roentgenol       Date:  1993-07       Impact factor: 3.959

Review 10.  Malignant fatty tumors: classification, clinical course, imaging appearance and treatment.

Authors:  Jeffrey J Peterson; Mark J Kransdorf; Laura W Bancroft; Mary I O'Connor
Journal:  Skeletal Radiol       Date:  2003-06-11       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.